These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4376058)

  • 1. The mechanism of action of soluble lymphocytic mediators. II. Modification of macrophage migration and migration inhibitory factor action by drugs, enzymes and cationic environment.
    Pick E; Manheimer S
    Cell Immunol; 1974 Mar; 11(1-3):30-46. PubMed ID: 4376058
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrophage migration inhibition factor: interactions with calcium, magnesium, and cyclic AMP.
    Block LH; Aloni B; Biemesderfer D; Kashgarian M; Bitensky MW
    J Immunol; 1978 Oct; 121(4):1416-21. PubMed ID: 212481
    [No Abstract]   [Full Text] [Related]  

  • 3. The mechanism of action of macrophage migration inhibitory factor (MIF).
    Pick E; Manheimer S
    Int Arch Allergy Appl Immunol; 1973; 45(1):295-8. PubMed ID: 4353769
    [No Abstract]   [Full Text] [Related]  

  • 4. Soluble lymphocytic mediators. I. Inhibition of macrophage migration inhibitory factor production by drugs.
    Pick E
    Immunology; 1974 Mar; 26(3):649-58. PubMed ID: 4369184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro modulation of human leucocyte migration and migration inhibitory factor (LIF) activity by cyclic 3',5'-AMP and cyclic 3',5'-GMP.
    Bendtzen K; Palit J
    Acta Pathol Microbiol Scand C; 1977 Feb; 85(1):78-80. PubMed ID: 190856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrophagocytosis by macrophages: suppression of heme oxygenase by cyclic AMP.
    Gemsa D; Woo CH; Webb D; Fudenberg HH; Schmid R
    Cell Immunol; 1975 Jan; 15(1):21-36. PubMed ID: 162778
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of cyclic AMP on leucocyte inhibitory factor (LIF) production and on the inhibition of leucocyte migration.
    Lomnitzer R; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1976 Apr; 24(1):42-8. PubMed ID: 181189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adjuvant activity of mycobacterial RNA preparations and synthetic polynucleotides for induction of delayed hypersensitivity to purified protein derivative in guinea pigs.
    Casavant CH; Youmans GP
    J Immunol; 1975 Mar; 114(3):1014-22. PubMed ID: 803534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of human leucocyte migration inhibitory factor (LIF) by 3',5'-cyclic AMP, 3',5'-cyclic GMP and agents known to influence intracellular cyclic nucleotide metabolism.
    Bendtzen K; Palit J
    Acta Pathol Microbiol Scand C; 1977 Oct; 85(5):317-23. PubMed ID: 200062
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of leukocyte migration by human tumors. Effect on patient survival.
    Wolberg WH
    Arch Surg; 1974 Aug; 109(2):211-4. PubMed ID: 4367758
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostaglandin and cyclic AMP regulation of macrophage involvement in connective tissue destruction.
    Wahl LM; Olsen CE; Wahl SM; McCarthy JB; Sandberg AL; Mergenhagen SE
    Ann N Y Acad Sci; 1979; 332():271-8. PubMed ID: 93863
    [No Abstract]   [Full Text] [Related]  

  • 12. Dependence of pancreatic enzyme secretion on extracellular Ca++ and its modification by cyclic nucleotides and thyrocalcitonin.
    Schulz I; Mannigel H
    Acta Gastroenterol Belg; 1974 Sep; 37(9):402-12. PubMed ID: 4376324
    [No Abstract]   [Full Text] [Related]  

  • 13. The activation of mononuclear phagocytes in vitro: immunologically mediated enhancement.
    Adams DO; Biesecker JL; Koss LG
    J Reticuloendothel Soc; 1973 Dec; 14(6):550-70. PubMed ID: 4204505
    [No Abstract]   [Full Text] [Related]  

  • 14. Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.
    Youngner JS; Salvin SB
    J Immunol; 1973 Dec; 111(6):1914-22. PubMed ID: 4356326
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of 2-deoxy-D-glucose transport by theophylline, caffeine and papaverine in alveolar macrophages.
    Khandwala AS; Gee JB
    Biochem Pharmacol; 1974 Jun; 23(12):1781-6. PubMed ID: 4367039
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation between mitogenicity and stimulation of calcium uptake in human lymphocytes.
    Parker CW
    Biochem Biophys Res Commun; 1974 Dec; 61(4):1180-6. PubMed ID: 4376005
    [No Abstract]   [Full Text] [Related]  

  • 17. Yin/Yang modulation of lysosomal enzyme release from polymorphonuclear leukocytes by cyclic nucleotides.
    Weissmann G; Goldstein I; Hoffstein S; Chauvet G; Robineaux R
    Ann N Y Acad Sci; 1975 Jun; 256():222-32. PubMed ID: 169720
    [No Abstract]   [Full Text] [Related]  

  • 18. The mechanism of action of soluble lymphocyte mediators. IV. Effect of migratio inhibitory factor (MIF) on macrophage cyclic AMP and on responsiveness to adenylate cyclase stimulators.
    Pick E
    Cell Immunol; 1977 Aug; 32(2):329-39. PubMed ID: 198144
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets.
    Malmsten C; Granström E; Samuelsson B
    Biochem Biophys Res Commun; 1976 Jan; 68(2):569-76. PubMed ID: 175797
    [No Abstract]   [Full Text] [Related]  

  • 20. The mechanism of action of soluble lymphocytic mediators. I. A pulse exposure test for the measurement of macrophage migration inhibitory factor.
    Manheimer S; Pick E
    Immunology; 1973 Jun; 24(6):1027-34. PubMed ID: 4736924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.